Back
PetMed Express 10K Form
Sell
28
PETS
PetMed Express
Last Price:
16.24
Seasonality Move:
15.33%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2020-08-03 | 10Q | PETS/PetMed Express Quarterly |
2020-05-26 | 10K | PETS/PetMed Express Annual |
2020-01-28 | 10Q | PETS/PetMed Express Quarterly |
2019-10-30 | 10Q | PETS/PetMed Express Quarterly |
2019-07-30 | 10Q | PETS/PetMed Express Quarterly |
2019-05-28 | 10K | PETS/PetMed Express Annual |
Receive PETS News And Ratings
See the #1 stock for the next 7 days that we like better than PETS
PETS Financial Statistics
Sales & Book Value
Annual Sales: | $273.42M |
---|---|
Cash Flow: | $11.98M |
Price / Cash Flow: | 14.35 |
Annual Sales: | $6.34 |
Price / Book: | 2.56 |
Profitability
EPS (TTM): | 0.56910 |
---|---|
Net Income (TTM): | $11.4M |
Gross Margin: | $78.08M |
Return on Equity: | 8.2% |
Return on Assets: | 6.76% |
PetMed Express Earnings Forecast
Key PetMed Express Financial Ratios
- The Gross Profit Margin over the past 23 years for PETS is 28.56%.
- The Selling, General & Administrative Expenses for PETS have been equal to 18.15% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of PETS is 7.72% of Total Revenues.
- Per Share Earnings over the last 23 years have been positive in 16 years.
PetMed Express Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Pharmaceutical Retailers |
Sector: | Healthcare |
Current Symbol: | PETS |
CUSIP: | 716382 |
Website: | petmeds.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 4.31 |
Quick Ratio: | 3.36 |
Price-to-Earnings
Trailing P/E Ratio: | 15.61 |
---|---|
Forward P/E Ratio: | 14.36 |
PETS Technical Analysis vs Fundamental Analysis
Sell
28
PetMed Express (PETS)
is a Sell
Is PetMed Express a Buy or a Sell?
-
PetMed Express stock is rated a Sell
The current PetMed Express [PETS] share price is $16.23. The Score for PETS is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.